Stay updated with breaking news from Christopher Recknor. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
22.06.2022 - VANCOUVER, Washington, June 22, 2022 (GLOBE NEWSWIRE) - CytoDyn Inc. (OTCQB: CYDY) ('CytoDyn' or the 'Company'), a late-stage biotechnology company developing leronlimab, a CCR5 antagonist with the potential for multiple therapeutic indications, ...
.jpg)
A glance at some of the day's highlights from the Proactive Investors US and Canada newswires
A glance at some of the day's highlights from the Proactive Investors US and Canada newswires
VANCOUVER, Washington, Jan. 11, 2022 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTCQB: CYDY) ("CytoDyn" or the "Company"), a late-stage biotechnology company...
.jpg)
A glance at some of the day's highlights from the Proactive Investors US and Canada newswires